Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Telesta Therapeutics Inc. T.TST

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  BNHLF

Telesta Therapeutics Inc is a human therapeutics company. The Company is engaged in the manufacturing, marketing and licensing/acquisition of proprietary therapies for the global human health market.
Price: $0.355 | Change: $-0.02 | %Change: -5.33%
Volume: 21,000 | Day High/Low: 0.36/0.355 | 52 Week High/Low: 0.40/0.175
View modes: 
0 stars

rember this

Urocidin in non-muscle-invasive bladder cancer discontinued......trial not recruiting at the expected rate ...........  rate and reply
0 stars

RE:RE: nearly all...haa

sheet-io i see you did not take the weekend off from writing the same BS give it up and go away  rate and reply
0 stars

RE: nearly all...haa

554....geez.. must be great hey ..having the Docs and interested patients  rate and reply
0 stars

nearly all...haa

quote.......FDA said it receives about 550 applications a year from drug companies to supply drugs to individuals before final approval and agrees to nearly all of them. .  rate and reply
0 stars

RE:RE:RE:odds unpredictable

We hope it could be corrected. But if they are not receptive to our BLA filing we can't get to the review. First things first, approval is the most important event at this time.  rate and reply
1 star

RE:RE:odds unpredictable

- not having a submission accepted wouldn't be disasterous.  It would simply mean some element of the data package was missing. It could be corrected.  However, gettting the filing acccepted means...read more
0 stars

RE:odds unpredictable

True we don't need orphan status, priority review would be nice, but not having our submission accepted would be disastrous. How could it be otherwise?  rate and reply
1 star

odds unpredictable

Neither acceptance of filing, fast track approval, or rejection of orphan status has any bearing on whether we get our license.  rate and reply
0 stars

RE:RE:RE:RE:There Will Soon Be Trading Day Where Our SP Rises!

I wasn't considering the sp, I was addressing our overall chances of success, sp will Improve when regulatory risk is removed. Personally I think the major risk is still with acceptance of our...read more
0 stars

RE:RE:There Will Soon Be Trading Day Where Our SP Rises!

I say if we get the fast rack we will hit $1.00 before the end of the year. At that point we will be noticed as a legitimate threat to go all the way.  rate and reply
0 stars

RE:RE:RE:There Will Soon Be Trading Day Where Our SP Rises!

T1 Although getting accepted is important and getting fast track status is important expecting  no issues with AdComm and having AdComm give us a thumbs up are not quite the same. We are a show me...read more
0 stars

RE:RE:There Will Soon Be Trading Day Where Our SP Rises!

I think if they accept our package and approve priority review that will move us beyond second base. It is hard to imagine with the previous trials results that AdComm will derail us, so the next...read more
1 star

RE:RE:sock it toooo em

decision would be left entirely in the hands of the patient, the doctor and the drug company............fcky ducky... The hip bone's connected to the back bone The back bone's connected to the neck...read more
1 star

RE:sock it toooo em

, State law. An experimental product is defined as one that has successfully completed a phase 1 clinical investigation, remains under investigation in an FDA-approved clinical trial, and is not FDA...read more
1 star

sock it toooo em

The Right to Try Act of 2015 A Serious Challenge to FDA Control of Expanded Access? By James C. Shehan On July 9, 2015, Representatives Matt Salmon (R- AZ), Paul Gosar (R-AZ) and Marlin Stutzman (R...read more
2.5 stars

RE:There Will Soon Be Trading Day Where Our SP Rises!

Let's not get ahead of ourselves. We have about a month to grind down then we move  to second base, but until the Fed gives us our filing thumbs up and fast track status be happy  with getting to .45...read more
0 stars

There Will Soon Be Trading Day Where Our SP Rises!

Easily by $1.00 increments. Calculate your 'on paper' profits girls and boys.  rate and reply
0 stars

RE:RE:Imagine that

you do not think so and you are right but if you were sheet-io you would be looking for anything potentially negative any blisters on your hands sheet-io  rate and reply
0 stars

RE:Imagine that

while this is true, in this case the FDA itself recommended that Telesta submit a BLA based on its current available data. I don't think that the data being insufficient is a huge risk in this case.  rate and reply
1 star

RE:RE:Imagine that

If yer lips were near...........I wouldn't need any hands  rate and reply